211 related articles for article (PubMed ID: 35095858)
21. Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice.
Zhao GH; Fang YQ; Ryan U; Guo YX; Wu F; Du SZ; Chen DK; Lin Q
Parasitol Res; 2016 Feb; 115(2):879-87. PubMed ID: 26593737
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
23. LncRNA XR_001779380 Primes Epithelial Cells for IFN-γ-Mediated Gene Transcription and Facilitates Age-Dependent Intestinal Antimicrobial Defense.
Gong AY; Wang Y; Li M; Zhang XT; Deng S; Chen JM; Lu E; Mathy NW; Martins GA; Strauss-Soukup JK; Chen XM
mBio; 2021 Oct; 12(5):e0212721. PubMed ID: 34488445
[TBL] [Abstract][Full Text] [Related]
24. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum.
Ras R; Huynh K; Desoky E; Badawy A; Widmer G
Int J Parasitol; 2015 Jul; 45(8):567-73. PubMed ID: 25913477
[TBL] [Abstract][Full Text] [Related]
25. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
Theodos CM; Sullivan KL; Griffiths JK; Tzipori S
Infect Immun; 1997 Nov; 65(11):4761-9. PubMed ID: 9353062
[TBL] [Abstract][Full Text] [Related]
26. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection.
Chen XM; Splinter PL; O'Hara SP; LaRusso NF
J Biol Chem; 2007 Sep; 282(39):28929-28938. PubMed ID: 17660297
[TBL] [Abstract][Full Text] [Related]
27. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
Rasmussen KR; Healey MC; Cheng L; Yang S
J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
[TBL] [Abstract][Full Text] [Related]
28. Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.
Ferguson SH; Foster DM; Sherry B; Magness ST; Nielsen DM; Gookin JL
Cell Mol Gastroenterol Hepatol; 2019; 8(1):1-20. PubMed ID: 30849550
[TBL] [Abstract][Full Text] [Related]
29. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
Tarazona R; Blewett DA; Carmona MD
Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
[TBL] [Abstract][Full Text] [Related]
32. Dual Transcriptomics To Determine Gamma Interferon-Independent Host Response to Intestinal Cryptosporidium parvum Infection.
Gallego-Lopez GM; Mendoza Cavazos C; Tibabuzo Perdomo AM; Garfoot AL; O'Connor RM; Knoll LJ
Infect Immun; 2022 Feb; 90(2):e0063821. PubMed ID: 34928716
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
34. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum.
O'Hara SP; Small AJ; Gajdos GB; Badley AD; Chen XM; Larusso NF
J Infect Dis; 2009 Apr; 199(8):1195-204. PubMed ID: 19265483
[TBL] [Abstract][Full Text] [Related]
36. Cryptosporidium parvum: the course of Cryptosporidium parvum infection in C57BL/6 mice co-infected with the nematode Heligmosomoides bakeri.
Bednarska M; Bajer A; Sinski E
Exp Parasitol; 2008 Sep; 120(1):21-8. PubMed ID: 18522859
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
Gamra MM; el-Hosseiny LM
J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
[TBL] [Abstract][Full Text] [Related]
38. Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes.
Perez-Cordon G; Yang G; Zhou B; Nie W; Li S; Shi L; Tzipori S; Feng H
Pathog Dis; 2014 Feb; 70(1):17-27. PubMed ID: 23913680
[TBL] [Abstract][Full Text] [Related]
39. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
[TBL] [Abstract][Full Text] [Related]
40. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
